SUNFISH Parts 1 and 2: 4-year efficacy and safety data of risdiplam in Types 2 and 3 spinal muscular atrophy (SMA) Kostera-Pruszczyk, A., Day, J., Deconinck, N., Mazzone, E., Nascimento, A., Oskoui, M., Saito, K., Vuillerot, C., Baranello, G., Boespflug-Tanguy, O., Goemans, N., Kirschner, J., Servais, L., Braid, J., Gerber, M., Gorni, K., Martin, C., Yeung, W., Scalco, R., Mercuri, E. WILEY. 2023: 194

View details for Web of Science ID 001058307000261